{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:35:56Z","timestamp":1790840156585,"version":"4.1.0"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01316","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T04:54:34Z","timestamp":1560228874000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":62,"title":["Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development"],"prefix":"10.3389","volume":"10","author":[{"given":"Annie","family":"Elong Ngono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujan","family":"Shresta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev-immunol-031210-101315","article-title":"Immune response to dengue virus and prospects for a vaccine","volume":"29","author":"Murphy","year":"2011","journal-title":"Annu Rev Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.4269\/ajtmh.1989.40.571","article-title":"Aedes aegypti and Aedes aegypti-borne disease control in the 1990s: top down or bottom up","volume":"40","author":"Gubler","year":"1989","journal-title":"Charles Franklin Craig Lecture Am J Trop Med Hyg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1099\/0022-1317-70-1-37","article-title":"Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera","volume":"70","author":"Calisher","year":"1989","journal-title":"J Gen Virol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature."},{"key":"B5","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/oxfordjournals.aje.a113932","article-title":"Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak","volume":"120","author":"Sangkawibha","year":"1984","journal-title":"Am J Epidemiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","article-title":"Dengue","volume":"370","author":"Halstead","year":"2007","journal-title":"Lancet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science."},{"key":"B8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-immunol-042617-053142","article-title":"Immune Response to Dengue and Zika","volume":"36","author":"Ngono","year":"2018","journal-title":"Annu Rev Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41586-018-0157-4","article-title":"Reconstruction of antibody dynamics and infection histories to evaluate dengue risk","volume":"557","author":"Salje","year":"2018","journal-title":"Nature."},{"key":"B10","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nm887","article-title":"Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever","volume":"9","author":"Mongkolsapaya","year":"2003","journal-title":"Nat Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40475-013-0009-0","article-title":"Immunopathogenesis versus protection in dengue virus infections","volume":"1","author":"Rothman","year":"2014","journal-title":"Curr Trop Med Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.1016\/j.vaccine.2015.11.023","article-title":"Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies","volume":"34","author":"Coudeville","year":"2016","journal-title":"Vaccine."},{"key":"B13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7229","DOI":"10.1016\/j.vaccine.2011.06.094","article-title":"From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine","volume":"29","author":"Guy","year":"2011","journal-title":"Vaccine."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1016\/j.vaccine.2008.08.019","article-title":"Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects","volume":"26","author":"Guy","year":"2008","journal-title":"Vaccine."},{"key":"B17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0140-6736(16)00006-4","article-title":"Zika virus in Brazil and macular atrophy in a child with microcephaly","volume":"387","author":"Ventura","year":"2016","journal-title":"Lancet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"11259","DOI":"10.1128\/JVI.01424-16","article-title":"Characterization of human CD8 T Cell responses in dengue virus-infected patients from India","volume":"90","author":"Chandele","year":"2016","journal-title":"J Virol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"16922","DOI":"10.1073\/pnas.1010867107","article-title":"Immunodominant T-cell responses to dengue virus NS3 are associated with DHF","volume":"107","author":"Duangchinda","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.4049\/jimmunol.1301507","article-title":"Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity","volume":"191","author":"Rivino","year":"2013","journal-title":"J Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3389\/fimmu.2017.01309","article-title":"Global assessment of dengue virus-specific CD4(+) T cell responses in dengue-endemic areas","volume":"8","author":"Grifoni","year":"2017","journal-title":"Front Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/infdis\/jiw309","article-title":"HLA-DRB1 alleles are associated with different magnitudes of dengue virus-specific CD4+ T-Cell responses","volume":"214","author":"Weiskopf","year":"2016","journal-title":"J Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e02147","DOI":"10.1128\/JVI.02147-16","article-title":"Human CD4(+) T cell responses to an attenuated tetravalent dengue vaccine parallel those induced by natural infection in magnitude, HLA restriction, and antigen specificity","volume":"91","author":"Angelo","year":"2017","journal-title":"J Virol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature."},{"key":"B26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fimmu.2014.00151","article-title":"Mouse models to study dengue virus immunology and pathogenesis","volume":"5","author":"Zellweger","year":"2014","journal-title":"Front Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.4049\/jimmunol.1101970","article-title":"Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design","volume":"187","author":"Weiskopf","year":"2011","journal-title":"J Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"11383","DOI":"10.1128\/JVI.01108-14","article-title":"Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection","volume":"88","author":"Weiskopf","year":"2014","journal-title":"J Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/infdis\/jiv289","article-title":"Human CD8+ T-cell responses against the 4 dengue virus serotypes are associated with distinct patterns of protein targets","volume":"212","author":"Weiskopf","year":"2015","journal-title":"J Infect Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1128\/JVI.02675-12","article-title":"Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection","volume":"87","author":"Rivino","year":"2013","journal-title":"J Virol."},{"key":"B31","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1128\/JVI.67.10.5962-5967.1993","article-title":"Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination","volume":"67","author":"Green","year":"1993","journal-title":"J Virol."},{"key":"B32","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4049\/jimmunol.154.3.1287","article-title":"Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities","volume":"154","author":"Livingston","year":"1995","journal-title":"J Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e20581","DOI":"10.1371\/journal.pone.0020581","article-title":"HLA class I and class II associations in dengue viral infections in a Sri Lankan population","volume":"6","author":"Malavige","year":"2011","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"0013029","DOI":"10.1371\/journal.pone.0013029","article-title":"Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population","volume":"5","author":"Appanna","year":"2010","journal-title":"PLoS ONE."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e304","DOI":"10.1371\/journal.pntd.0000304","article-title":"Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome","volume":"2","author":"Nguyen","year":"2008","journal-title":"PLoS Negl Trop Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e01469","DOI":"10.1128\/JVI.01469-17","article-title":"Prior dengue virus exposure shapes T cell immunity to Zika virus in humans","volume":"91","author":"Grifoni","year":"2017","journal-title":"J Virol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"17036","DOI":"10.1038\/nmicrobiol.2017.36","article-title":"Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells","volume":"2","author":"Wen","year":"2017","journal-title":"Nat Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41467-017-01669-z","article-title":"Dengue virus-reactive CD8(+) T cells mediate cross-protection against subsequent Zika virus challenge","volume":"8","author":"Wen","year":"2017","journal-title":"Nat Commun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1038\/s41467-018-05458-0","article-title":"Cross-reactive Dengue virus-specific CD8(+) T cells protect against Zika virus during pregnancy","volume":"9","author":"Regla-Nava","year":"2018","journal-title":"Nat Commun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e01992","DOI":"10.1128\/JVI.01992-17","article-title":"Sustained specific and cross-reactive T cell responses to zika and dengue virus NS3 in West Africa","volume":"92","author":"Herrera","year":"2018","journal-title":"J Virol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.3389\/fimmu.2018.02225","article-title":"Cross-reactivity and anti-viral function of dengue capsid and NS3-specific memory T cells toward zika virus","volume":"9","author":"Lim","year":"2018","journal-title":"Front Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1086\/315072","article-title":"Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever","volume":"180","author":"Green","year":"1999","journal-title":"J Infect Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1086\/340822","article-title":"Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren","volume":"185","author":"Mangada","year":"2002","journal-title":"J Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ebiom.2017.04.033","article-title":"The role of heterotypic DENV-specific CD8(+)T Lymphocytes in an immunocompetent mouse model of secondary dengue virus infection","volume":"20","author":"Talarico","year":"2017","journal-title":"EBioMedicine."},{"key":"B45","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1126\/scitranslmed.aal5088","article-title":"Increased adaptive immune responses and proper feedback regulation protect against clinical dengue","volume":"9","author":"Simon-Loriere","year":"2017","journal-title":"Sci Transl Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e0006540","DOI":"10.1371\/journal.pntd.0006540","article-title":"Quantification of dengue virus specific T cell responses and correlation with viral load and clinical disease severity in acute dengue infection","volume":"12","author":"Wijeratne","year":"2018","journal-title":"PLoS Negl Trop Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4049\/jimmunol.1102124","article-title":"Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells","volume":"188","author":"Zompi","year":"2012","journal-title":"J Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"6494","DOI":"10.1128\/JVI.00036-15","article-title":"CD8+ T cells can mediate short-term protection against heterotypic dengue virus reinfection in mice","volume":"89","author":"Zellweger","year":"2015","journal-title":"J Virol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ebiom.2016.10.006","article-title":"Protective role of cross-reactive CD8 T cells against dengue virus infection","volume":"13","author":"Elong","year":"2016","journal-title":"EBioMedicine."},{"key":"B50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1128\/JVI.02129-14","article-title":"The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes","volume":"89","author":"Weiskopf","year":"2015","journal-title":"J Virol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1128\/JVI.02892-15","article-title":"Immunodominant dengue virus-specific CD8+ T cell responses are associated with a memory PD-1+ phenotype","volume":"90","author":"De","year":"2016","journal-title":"J Virol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"278ra35","DOI":"10.1126\/scitranslmed.aaa0526","article-title":"Virus-specific T lymphocytes home to the skin during natural dengue infection","volume":"7","author":"Rivino","year":"2015","journal-title":"Sci Transl Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"E4256","DOI":"10.1073\/pnas.1505956112","article-title":"Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity","volume":"112","author":"Weiskopf","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B54","doi-asserted-by":"publisher","first-page":"aan8664","DOI":"10.1126\/sciimmunol.aan8664","article-title":"Precursors of human CD4(+) cytotoxic T lymphocytes identified by single-cell transcriptome analysis","volume":"3","author":"Patil","year":"2018","journal-title":"Sci Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/infdis\/jiy360","article-title":"Activation of peripheral T follicular helper cells during acute dengue virus infection","volume":"218","author":"Haltaufderhyde","year":"2018","journal-title":"J Infect Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"274","DOI":"10.20411\/pai.v2i2.188","article-title":"T-cell Responses in Individuals Infected with Zika Virus and in Those Vaccinated Against Dengue Virus","volume":"2","author":"Paquin-Proulx","year":"2017","journal-title":"Pathog Immun."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e00900","DOI":"10.1128\/JVI.00900-17","article-title":"CD8+ T cell immune response in immunocompetent mice during zika virus infection","volume":"91","author":"Huang","year":"2017","journal-title":"J Virol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1172\/JCI75429","article-title":"Immune activation alters cellular and humoral responses to yellow fever 17D vaccine","volume":"124","author":"Muyanja","year":"2014","journal-title":"J Clin Invest."},{"key":"B59","doi-asserted-by":"publisher","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"Akondy","year":"2009","journal-title":"J Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet."},{"key":"B61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrmicro.2015.2","article-title":"Dengue vaccine: hypotheses to understand CYD-TDV-induced protection","volume":"14","author":"Guy","year":"2016","journal-title":"Nat Rev Microbiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.4161\/hv.25562","article-title":"Persistence of Th1\/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore","volume":"9","author":"Harenberg","year":"2013","journal-title":"Hum Vaccin Immunother."},{"key":"B63","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/infdis\/jis936","article-title":"A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial","volume":"207","author":"Durbin","year":"2013","journal-title":"J Infect Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1093\/infdis\/jiv258","article-title":"CD8+ T-cell responses in flavivirus-naive individuals following immunization with a live-attenuated tetravalent dengue vaccine candidate","volume":"212","author":"Chu","year":"2015","journal-title":"J Infect Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coviro.2017.03.006","article-title":"Vaccination strategies against Zika virus","volume":"23","author":"Fernandez","year":"2017","journal-title":"Curr Opin Virol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against Zika virus from Brazil","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature."},{"key":"B67","doi-asserted-by":"publisher","first-page":"aao4163","DOI":"10.1126\/scitranslmed.aao4163","article-title":"Durability and correlates of vaccine protection against Zika virus in rhesus monkeys","volume":"9","author":"Abbink","year":"2017","journal-title":"Sci Transl Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"10498","DOI":"10.1038\/s41598-017-10901-1","article-title":"Prior exposure to zika virus significantly enhances peak dengue-2 viremia in rhesus macaques","volume":"7","author":"George","year":"2017","journal-title":"Sci Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.chom.2018.09.015","article-title":"Maternally acquired zika antibodies enhance dengue disease severity in mice","volume":"24","author":"Fowler","year":"2018","journal-title":"Cell Host Microbe."},{"key":"B70","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e25685","DOI":"10.1371\/journal.pone.0025685","article-title":"Induction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines","volume":"6","author":"Costa","year":"2011","journal-title":"PLoS ONE."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e1003723","DOI":"10.1371\/journal.ppat.1003723","article-title":"Role of humoral versus cellular responses induced by a protective dengue vaccine candidate","volume":"9","author":"Zellweger","year":"2013","journal-title":"PLoS Pathog."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01316\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T10:17:08Z","timestamp":1694945828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01316\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":72,"alternative-id":["10.3389\/fimmu.2019.01316"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01316","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,11]]},"article-number":"1316"}}